Search Orphan Drug Designations and Approvals
-
| Generic Name: | fibroblast activation protein inhibitor radiolabeled with [18F] |
|---|---|
| Date Designated: | 05/22/2025 |
| Orphan Designation: | diagnostic for the management of esophageal cancer |
| Orphan Designation Status: | Designated |
| FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
| Sponsor: |
SOFIE Co. dba SOFIE 21000 Atlantic Blvd. Dulles, Virginia 20166 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-







